Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Lymphoma × penpulimab × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gene Expression Profiling 10 Surveys and Questionnaires 8 Polymerase Chain Reaction 8 Amplified Fragment Length Polymorphism Analysis 8 Immunohistochemistry 7 Flow Cytometry 7 Psychiatric Rehabilitation 6 Microarray Analysis 6 Rituximab 4 Interviews as Topic 4 Biopsy 4 Immunologic Techniques 3 Gene Rearrangement 3 Doxorubicin 3 Data Collection 3 Cytogenetic Analysis 3 Cyclophosphamide 3 plerixafor 2 Vincristine 2 Therapeutics 2 Prednisone 2 Positron-Emission Tomography 2 Phlebotomy 2 Pharmacogenomic Testing 2 Observation 2 Mental Status and Dementia Tests 2 Magnetic Resonance Spectroscopy 2 Leukapheresis 2 Lenalidomide 2 In Situ Hybridization, Fluorescence 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05680038 2023-01-11

Penpulimab in Maintenance Therapy in Lymphoma

The First Affiliated Hospital with Nanjing Medical University

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡